GlassScriptPhysician profile
Vadim Divilov
NPI 1841678422
$8,907.43
in general payments reported to CMS, 2019-2025
17 companies · $1,632 in 2025
The $1,632 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $123 · 2021: $1,021 · 2022: $1,052 · 2023: $3,155 · 2024: $1,926 · 2025: $1,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,482 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,481.95 |
| Education | $230.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,669.00 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Genzyme Corporation | $1,371.57 | 2022-2025 | |
| Glaxosmithkline, LLC. | $949.36 | 2021-2025 | Nucala, Trelegy Ellipta |
| Astellas Pharma US INC | $746.60 | 2021-2023 | Cresemba |
| Boehringer Ingelheim Pharmaceuticals, INC. | $731.28 | 2023-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $566.98 | 2021-2025 | Dupixent |
| Csl Behring | $480.62 | 2022-2025 | Kcentra |
| Actelion Pharmaceuticals US, INC. | $246.09 | 2024-2025 | Opsumit, Uptravi |
| Shionogi INC | $241.63 | 2023-2025 | Fetroja |
| Amgen INC. | $232.37 | 2021-2024 | Tavneos |
| Genentech USA, INC. | $201.52 | 2021 | |
| Janssen Pharmaceuticals, INC | $179.88 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $106.67 | 2022 | |
| Insmed, INC. | $82.13 | 2022-2025 | Brinsupri, Arikayce |
| Verona Pharma, INC. | $52.10 | 2025 | Ohtuvayre |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $28.66 | 2025 | |
| Ani Pharmaceuticals, INC. | $20.97 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Divilov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.